胫骨近端Rosai-Dorfman病误诊一例

doi:10.3760/cma.j.cn101202-20190314-00091

摘要
图/表
参考文献
相关文章 (15)

[1]	Foucar E, Rosai J, Dorfman R. Sinus Histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity[J]. Semin Diagn Pathol, 1990, 7(1): 19-73.
[2]	Mosheimer BA, Oppl B, Zandieh S, et al. Bone involvement in rosai-dorfman disease (RDD): a case report and systematic literature review[J]. Curr Rheumatol Rep, 2017, 19(5): 29. DOI:10.1007/s11926-017-0656-6.
[3]	Sundaram M, deMello D, Falbo S, et al. Sinus Histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) presenting with skeletal lesions[J]. Skeletal Radiol, 1998, 27(2): 115-117. DOI:10.1007/s002560050349.
[4]	Mantilla JG, Goldberg-Stein S, Wang Y. Extranodal rosai-dorfman disease: clinicopathologic series of 10 patients with radiologic correlation and review of the literature[J]. Am J Clin Pathol, 2016, 145(2): 211-221. DOI:10.1093/ajcp/aqv029.
[5]	Lee H, King G, Garg K, et al. Successful treatment of disseminated rosai-dorfman disease with siltuximab[J]. Haematologica, 2018, 103(7): e325-e328. DOI:10.3324/haematol.2018.188441.
[6]	Garces S, Medeiros LJ, Patel KP, et al. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease[J]. Mod Pathol, 2017, 30(10): 1367-1377. DOI:10.1038/modpathol.2017.55.
[7]	Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages[J]. Blood, 2016, 127(22): 2672-2681. DOI:10.1182/blood-2016-01-690636.
[8]	Menon MP, Evbuomwan MO, Rosai J, et al. A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease?[J]. Histopathology, 2014, 64(3): 455-459. DOI:10.1111/his.12274.
[9]	Shanmugam V, Margolskee E, Kluk M, et al. Rosai-dorfman disease harboring an activating KRAS K117N missense mutation[J]. Head Neck Pathol, 2016, 10(3): 394-399. DOI:10.1007/s12105-016-0709-6.
[10]	Yu JQ, Zhuang H, Xiu Y, et al. Demonstration of increased FDG activity in Rosai-Dorfman disease on positron emission tomography[J]. Clin Nucl Med, 2004, 29(3): 209-210. DOI:10.1097/01.rlu.0000114018.07676.15.
[11]	Dhull VS, Passah A, Rana N, et al. 18F-FDG PET/CT of widespread rosai-dorfman disease[J]. Clin Nucl Med, 2016, 41(1): 57-59. DOI:10.1097/rlu.0000000000001002.
[12]	Albano D, Bosio G, Bertagna F. 18F-FDG PET/CT follow-up of rosai-dorfman disease[J]. Clin Nucl Med, 2015, 40(8): e420-e422. DOI:10.1097/RLU.0000000000000853.